false
Catalog
Psychopharmacology Management of Early Psychosis D ...
Presentation Bibliography
Presentation Bibliography
Back to course
Pdf Summary
This is a session bibliography for a conference on Advancing Early Psychosis Care, specifically focusing on the topic of psychopharmacology management of early psychosis during the COVID-19 pandemic. The bibliography includes seven sources related to this topic. <br /><br />The first source is a study by Kahl and Correll discussing the management of patients with severe mental illness during the COVID-19 pandemic. The second source, by Türközer and Öngür, presents a projection for psychiatry in the post-COVID-19 era, discussing potential trends, challenges, and directions. <br /><br />The third source, by Bilbul et al., examines the psychopharmacology of COVID-19. It provides information on the effects of the virus on mental health and discusses potential treatment options. The fourth source, by Siskind et al., is a consensus statement on the use of clozapine during the pandemic. It provides guidelines for the use of this medication in patients with severe mental illness. <br /><br />The fifth source, by Viani-Walsh et al., focuses on the relationship between vitamin D deficiency in schizophrenia and implications for COVID-19 infection. It discusses the potential impact of vitamin D levels on the susceptibility to the virus. <br /><br />The sixth source, by Becker and Fiellin, addresses the intersection of the COVID-19 pandemic and the opioid crisis, highlighting the challenges faced by individuals with substance use disorders during this time. <br /><br />The final source, by Kozloff et al., discusses the implications of the COVID-19 pandemic for people with schizophrenia and related disorders. It highlights the potential impact of the pandemic on the mental health of this population. <br /><br />Overall, these sources provide valuable insights into the psychopharmacology management of early psychosis during the COVID-19 pandemic, addressing various aspects such as treatment guidelines, potential trends, challenges, and the impact of the pandemic on different populations.
Keywords
Advancing Early Psychosis Care
psychopharmacology management
COVID-19 pandemic
severe mental illness
post-COVID-19 era
treatment options
use of clozapine
vitamin D deficiency
schizophrenia
pandemic impact
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
×
Please select your language
1
English